Dated 15^th July 2021, Malaysia's health minister on Thursday said the country will stop administering the Covid-19 vaccine produced by China's Sinovac once its supplies end, as it has a sufficient number of other vaccines for its programme.

Malaysia will increasingly use the Pfizer-BioNTech mRNA vaccines, Minister Adham Baba told a news conference. The Southeast Asian country secured 12 million doses of the Sinovac vaccine so far, enough to cover 18.75% of the population.

But what about exceeding the point of 18.75% of the population?

How are we going to hit the 40.00% mark for herd immunity?

KANGER INTERNATIONAL BERHAD (“KANGER”) is by far one of the leading suppliers of Sinopharm vaccine in the country.

The company’s recent share price had also been on an increasing trend. Could we see more positive momentum for the company moving forward?